Associate Professor
Johns Hopkins University School of Medicine
Attending Physician
Johns Hopkins Hospital
Baltimore, Maryland
Session Moderator
SESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS
Presenter
SESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS
Presenter
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
Presenter
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
Presenter
SESSION 45: MORE HOT AORTIC TOPICS, PMEGS AND IDES, GRAFT CHOICES FOR COMPLEX AAAS AND TAAAS
Presenter
SESSION 88: MORE CAROTID RELATED NEW TOPICS RELATED TO GUIDELINES, TCAR, CAS, CEA, NEW DEVICES, MESH COVERED STENTS, DEALING WITH DISTAL (HIGH) CAROTID LESIONS, MINI-INCISION CEA AND TREATMENT OF POST-PROCEDURAL STROKES
Moderator
SESSION 4: Carotid Diseases
SESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS
Presenter
SESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS
Why Pre-Intervention Physiologic Testing Is Important In Determining Treatment Of Patients With Intermittent Claudication: When Is Invasive Treatment Justified
4:42 PM - 4:47 PM
Presenter
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
Weight Loss Semaglutide Drugs (Ozempic, Wegovy) Increase Walking Ability And ABIs In Diabetics With IC: The STRIDE RCT
4:56 PM - 5:01 PM
Presenter
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
Infrapopliteal Peripheral Vascular Interventions For IC Are Performed Frequently In The US And Are Associated With Poor Long-Term Outcomes: What Specialty And Sites Of Treatment Are Most Involved And What Should Be Done About It
5:08 PM - 5:13 PM
Presenter
SESSION 45: MORE HOT AORTIC TOPICS, PMEGS AND IDES, GRAFT CHOICES FOR COMPLEX AAAS AND TAAAS
Hospitals Without Investigational Device Exemptions (IDEs) Have Worse Outcomes After PMEGs: These Are Often Unreported And Not In The VQI
3:24 PM - 3:29 PM
Presenter
SESSION 88: MORE CAROTID RELATED NEW TOPICS RELATED TO GUIDELINES, TCAR, CAS, CEA, NEW DEVICES, MESH COVERED STENTS, DEALING WITH DISTAL (HIGH) CAROTID LESIONS, MINI-INCISION CEA AND TREATMENT OF POST-PROCEDURAL STROKES
Trends In Use Of CEA, CAS, And TCAR Before And After Medicare's Expansion Of Reimbursement For Carotid Stenting: Why Medicare's Recent Expansion Of Reimbursement For Carotid Stenting Was Factually Unjustified
10:36 AM - 10:41 AM
Moderator
SESSION 4: Carotid Diseases
VASCULAR FELLOWS & RESIDENTS CAREER DEVELOPMENT PROGRAM
FRIDAY, NOVEMBER 21, 2025
AMERICAS HALL 1 NORTH, 3RD FLOOR
PRESENTER
1:25 P.M. – 1:33 P.M.
Incorporating Social-Media Into Your Vascular Practice
FRIDAY, NOVEMBER 21, 2025
AMERICAS HALL 1 NORTH, 3RD FLOOR
PRESENTER
1:25 P.M. – 1:33 P.M.
Incorporating Social-Media Into Your Vascular Practice

